Back to Search
JARRYD ROSSIGNOL, DO
DO
Family Medicine Physician
NPI: 1063867489IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
MED-RES.LIC 52134(MT)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
DO2904(ME)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE
Class of 2016
Research & Publications (20)
Cryptosporidium and Giardia: treatment options and prospects for new drugs.
PMID 19632225·Exp Parasitol·2010
8-other
Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.
PMID 19135998·Gastroenterology·2009
2-rct
Thiazolides, a new class of anti-influenza molecules targeting viral hemagglutinin at the post-translational level.
PMID 19638339·J Biol Chem·2009
7-preclinical
Thiazolides: a new class of antiviral drugs.
PMID 19442032·Expert Opin Drug Metab Toxicol·2009
6-review
Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C.
PMID 18811238·Future Microbiol·2008
6-review
Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4.
PMID 18616643·Aliment Pharmacol Ther·2008
4-observational
Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial.
PMID 17081163·Aliment Pharmacol Ther·2006
3-trial
Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species.
PMID 16527695·Clin Gastroenterol Hepatol·2006
4-observational
Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial.
PMID 16829296·Lancet·2006
2-rct
Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.
PMID 16918894·Aliment Pharmacol Ther·2006
3-trial
Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis.
PMID 16234044·Clin Gastroenterol Hepatol·2005
2-rct
Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
PMID 11398117·J Infect Dis·2001
3-trial
Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide.
PMID 11443569·J Infect Dis·2001
3-trial
Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.
PMID 19133801·Clin Infect Dis·2009
4-observational
A novel (epsilongammadeltabeta)(o)-thalassemia deletion associated with an alpha globin gene triplication leading to a severe transfusion dependent fetal thalassemic syndrome.
PMID 19286882·Haematologica·2009
8-other
In vitro efficacy of nitro- and halogeno-thiazolide/thiadiazolide derivatives against Sarcocystis neurona.
PMID 19369006·Vet Parasitol·2009
7-preclinical
Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides.
PMID 19370775·World J Gastroenterol·2009
8-other
Effects of nitazoxanide on pharmacokinetics and pharmacodynamics of a single dose of warfarin.
PMID 19386947·Am J Health Syst Pharm·2009
3-trial
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.
PMID 19664635·Gastroenterology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 123 S 27TH ST
BILLINGS, MT 59101 - Phone
- (406) 247-3330
Quick Facts
- NPI
- 1063867489
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile